Sappro, Japan

Eiko Ohtsuka


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 372(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Eiko Ohtsuka: Innovator in RNA Biochemistry**

Introduction

Eiko Ohtsuka, an accomplished inventor from Sapporo, Japan, has made significant contributions to the field of biochemistry. With a focus on RNA compounds and their applications, Ohtsuka's work exemplifies the intersection of innovation and scientific research.

Latest Patents

Ohtsuka holds a patent for "Compounds for the cleavage at a specific position of RNA, oligomers." This groundbreaking invention involves a compound that consists of a double chain incorporating RNA and complementary DNA. The invention is particularly notable for its capability to cleave RNA at specific positions when exposed to an enzyme with ribonuclease H activity. Thus, it opens pathways for creating deletion mutants, which can be valuable in various biotechnological applications.

Career Highlights

Throughout her career, Ohtsuka has been associated with Ajinomoto Co., Ltd., a prominent company dedicated to health and nutrition. Under her leadership and innovation, the company has enhanced its research capabilities in biochemical applications related to RNA and DNA technologies.

Collaborations

Working alongside esteemed colleagues Hideo Inoue and Hirokazu Morisawa, Ohtsuka has fostered a collaborative environment that promotes groundbreaking research. This teamwork has led to advancements in understanding RNA interactions and has broadened the scope of applications for their inventions.

Conclusion

Eiko Ohtsuka's contributions to the field of RNA biochemistry stand as a testament to her innovative spirit and scientific prowess. Her patent, along with her collaborative efforts at Ajinomoto Co., Ltd., highlights the importance of innovation in addressing complex biochemical challenges. As research continues to evolve, Ohtsuka's work paves the way for future innovations in genetic research and therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…